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A Kidney Exchange Clearinghouse in New England
By ALVIN E. ROTH,T AYFUN SO ¨NMEZ, AND M. UTKU U ¨ NVER*
In September, 2004, the Renal Transplant
Oversight Committee of New England ap-
proved the establishment of a clearinghouse for
kidney exchange, proposed by Francis Del-
monico, Susan Saidman, and the three authors
of this paper. We outline here the potential
gains from kidney exchange and discuss prac-
tical constraints encountered as we begin de-
signing and implementing a matching mechanism.
I. Background
In 2003 there were 8,665 transplants of de-
ceased donor kidneys for the approximately
60,000 patients waiting for such transplants in the
United States. While waiting, 3,436 patients died.
There were also 6,464 kidney transplants from
living donors (Scientiﬁc Registry of Transplant
Recipients web site).
1 Live donation is an option
for kidneys, since healthy people have two and
can remain healthy with one. While it is illegal to
buy or sell organs, there have started to be kidney
exchanges involving two donor–patient pairs such
that each (living) donor cannot give a kidney to
the intended recipient because of blood type or
immunological incompatibility, but each patient
can receive a kidney from the other donor. So far
these have been rare: as of December 2004, only
ﬁve exchanges had been performed in the 14
transplant centers in New England. One reason
there have been so few kidney exchanges is that
there have not been databases of incompatible
patient–donor pairs. Incompatible donors were
simply sent home. (Databases are now being as-
sembled not only in New England, but also in
Ohio and Baltimore.)
Lainie Friedman Ross et al. (1997) discussed
the possibility of exchange between incompati-
ble patient–donor pairs. Not only have a few
such two-way exchanges been performed, but
two three-way exchanges (in which the donor
kidney from one pair is transplanted into the
patient in a second pair, whose donor kidney
goes to a third pair, whose donor kidney goes to
the ﬁrst pair) have been performed at Johns
Hopkins. There have also been a number of “list
exchanges” in which an incompatible patient–
donor pair makes a donation to someone on the
waiting list for a cadaver kidney, in return for
the patient in the pair receiving high priority for
a cadaver kidney when one becomes available.
II. Scope and Design of a Kidney
Clearinghouse:
In Roth et al. (2004a), we considered how to
organize all these kinds of exchanges efﬁ-
ciently, in a way that would give patients and
their doctors straightforward incentives. (Be-
cause medical information is decentralized,
some of the procedures for allocating cadaver
organs have experienced incentive problems.)
We modeled patients as having strict prefer-
ences over compatible kidneys, and we allowed
exchanges among any number of patient–donor
pairs (including not only incompatible pairs, but
also compatible pairs who might nevertheless
be able, through exchange, to obtain a preferred
kidney). We allowed list exchanges to be inte-
grated with live exchanges, so a patient–donor
pair who decided to exchange their kidney for
priority on the deceased donor list would not
necessarily donate their kidney to someone on
the list, but might instead donate their kidney to
another patient–donor pair who would in turn
donate a kidney to the list (or to another pair
who would in turn donate a kidney to the list,
etc.).
In our model each agent is a patient and her
donor(s). Agents have strict preferences over
other agents (based on compatibility, closeness
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376of tissue match, and age of donor), and over
priority on the cadaver wait-list.
If we exclude list exchange, this is the “hous-
ing market” of Lloyd Shapley and Herbert Scarf
(1974), and David Gale’s method of top trading
cycles (TTC) produces efﬁcient, core alloca-
tions. There is a unique such allocation (Roth
and Andrew Postlewaite, 1977), and the mech-
anism that selects it is dominant-strategy
incentive-compatible (Roth, 1982).
TTC works as follows: Each agent points to
her most preferred agent (the patient with the
agent’s favorite donor). There is at least one
cycle [an ordered list of agents (a1, a2, ... , an)i n
which each agent points to the next, and agent
an points to a1], and no agent can be part of
more than one cycle. The implied exchange in
each cycle is carried out, and the procedure
continues with each remaining agent pointing to
her favorite among the remaining agents.
When list exchange is included the model is
close to the “room assignment” of Atila Ab-
dulkadirog ˘lu and So ¨nmez (1999). At some point
of the TTC procedure there may be no cycles,
but only “w-chains” in which an is pointing to
the waiting list. An agent may be part of several
w-chains and therefore the procedure needs a
selection rule for w-chains. In Roth et al.
(2004a) we called this class of procedures top
trading cycles and chains (TTCC) and identiﬁed
a version that is Pareto efﬁcient and dominant-
strategy incentive-compatible.
To solve one aspect of the incentive problem,
all surgeries in a live-donor exchange are con-
ducted simultaneously. Thus a two-way ex-
change (involving just two patient–donor pairs)
involves four simultaneous surgeries, a three-
way exchange involves six, and so on.
III. Logistical Constraints:
Our medical colleagues worried that, at least
initially, they could not manage exchanges
larger than two-way. They were also inclined to
exclude list exchanges, and to allow only in-
compatible patient–donor pairs to participate.
As a ﬁrst approximation, their feeling was that a
patient should be indifferent between any com-
patible exchanges.
Therefore, in Roth et al. (2004b), each agent
is a patient with incompatible donors and is
indifferent between all donors compatible with
her. No exchange larger than two-way is feasi-
ble. Building on well-known results in graph
theory we showed that there are constrained-
efﬁcient dominant-strategy incentive-compatible
mechanisms. These include deterministic “pri-
ority” mechanisms like those organ banks use to
allocate cadaver organs, and stochastic mecha-
nisms that address equity considerations.
The gains from kidney exchange will depend
on several factors including:
(i) the size of the patient–donor database;
(ii) whether list exchanges are included (while
list exchanges have distributional implica-
tions for the deceased donor wait-list, their
inclusion increases the potential gains
from exchange);
(iii) the maximum number of transplants that
can be simultaneously carried out (equiv-
alently, the size of largest feasible cycle
and/or w-chain); and
(iv) whether compatible patient–donor pairs
can participate in exchange.
Consider pairs A and B: donor A is compat-
ible with both patients, but donor B is compat-
ible only with patient A. While donor A can
directly give her kidney to patient A, both pa-
tients receive a kidney if pairs A and B ex-
change. Such an exchange is called an
altruistically unbalanced exchange (E. Steve
Woodle and Ross, 1998) and is unlikely to be
recommended to couple A as long as such ex-
changes are unusual. But if patients have strict
preferences over donors, it could be that both
pairs obtain a preferred kidney from such an
exchange. (Consideration of compatible pairs,
and altruistically unbalanced exchanges, will
help us estimate an upper bound on the gains
that can be achieved.)
We turn to simulations to estimate the impact
of each of these factors on the number of pa-
tients who can beneﬁt from exchange.
IV. Simulations
For simplicity we consider non-blood-related
patient–donor pairs. Distributions of blood
types (48 percent O, 34 percent A, 14 percent B,
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and gender of the patients (41 percent female),
and percentage of spouses among the unrelated
donors (49 percent) are from the UNOS/OPTN
data.
2
Tissue-type incompatibility (a positive cross-
match) arises when a patient has antibodies
against a donor protein. (The positive cross-
match probability between female patients and
their husbands is approximately 33 percent,
compared to approximately 11 percent between
random pairs (Stefanos Zenios et al., 2000),
because antibodies can develop during child-
birth.) Patients in the UNOS database are di-
vided into three groups based on the odds that
they have a crossmatch with a random donor.
For simplicity we simulate patients in discrete
PRA (percent reactive antibody) levels:
(i) 70 percent low-PRA patients, each of
whom has a positive crossmatch probabil-
ity of 5 percent with a random donor,
(ii) 20 percent medium-PRA patients, each of
whom has a positive crossmatch probabil-
ity of 45 percent, and
(iii) 10 percent high-PRA patients, each of
whom has a positive crossmatch probabil-
ity of 90 percent.
We randomly simulate patient–donor pairs
using Monte-Carlo simulation size of 100 ran-
dom population constructions for each of the 16
scenarios described below:
(1) We consider two population sizes: 25 and
100.
(2) We consider including compatible pairs in
exchange as well as excluding them. (For
example, in a population of 25 patient-do-
nor pairs, if compatible pairs are excluded
from exchange, only the smaller number of
incompatible pairs will be available for ex-
change, and these will have a different dis-
tribution of characteristics than the general
population; O donors will be rare, and high
PRA patients will be more common.)
(3) Either
(a) list exchanges are unavailable; or
(b) list exchanges are available but only 40
percent of incompatible pairs consider
a transplant from a deceased donor and
only if a live donor is unavailable.
(4) The largest feasible cycle/w-chain is either
2 or unbounded.
These possibilities yield 2  2  2  2  16
scenarios, and for each realization we search for
a feasible exchange that includes the maximum
number of patients.
For simplicity we assume that patients are
indifferent between compatible live donors but
prefer any such donor to priority on the
deceased-donor wait-list. We use versions of
Jack Edmond’s (1965) algorithm to ﬁnd a max-
imal exchange when the largest feasible cycle/
w-chain is 2. We know of no efﬁcient algorithm
to determine a maximal exchange when cycle/
w-chain size is unbounded. In these scenarios
we search for a maximal exchange among efﬁ-
cient matchings via the TTCC algorithm.
Table 1 makes clear that the gains from all
kinds of exchange increase as the population n
of patient–donor pairs grows. The exchanges
that are initially likely to be achievable are those
involving no list exchange (0 percent wait-list),
and only incompatible patient–donor pairs.
When only two-way exchanges are feasible,
exchange yields on average an additional 3.96
such transplants when n  25 (16 percent of the
patient population), but 23.04 when n  100.
Allowing list exchange, or allowing larger than
two-way exchanges each gives a comparable
increase in the number of transplants that can be
achieved.
The largest gains in the table come from
including compatible pairs in the population
eligible for exchange. As the bottom of Ta-
ble 1 indicates, it is at least conceivable that in
a large population in which all patient–donor
pairs could participate in exchange, virtually
every patient (98.83 percent) with a willing
donor would be able to receive a kidney. But we
emphasize that this is an upper bound, since for
many compatible pairs, exchange will not be
desirable.
2 UNOS/OPTN 2003 Annual Report, 1993–2002 http://
www.optn.org. Patient characteristics are from new
waiting-list registrations, living donor relational type is
from living-donor transplants data.
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Kidney exchange is likely to proceed incre-
mentally, starting with the simplest cases (two-
way exchange) and the patients who can beneﬁt
most (incompatible pairs). Roth et al. (2005)
show that most of the gain from larger than
two-way exchange comes from three-way ex-
change, and so we are hopeful that it will be
possible to achieve these gains in the near term.
It may also be possible to include list exchanges
and nondirected donors (altruistic living donors
who do not specify a particular patient). Each of
these increases in the scope of exchange will
necessitate design changes in the clearinghouse,
and there are open theoretical problems remain-
ing for some of them (as is to be expected; cf.
the examples in Roth [2002]).
It seems likely that, until exchange becomes
well established, only incompatible patient–
donor pairs will be included, as surgeons will be
reluctant to advise compatible pairs not to pro-
ceed with their own transplant. However, as ex-
change becomes more routine, there will be
opportunities for mutually beneﬁcial exchange be-
tween, for example, a 25-year-old patient with a
compatible 50-year-old donor and a 50-year-old
patient with an incompatible 25-year-old donor.
Fortunately, the gains from even the simplest
exchanges are large, and achievable.
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